Page 4 - முடுக்கப்பட்ட News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from முடுக்கப்பட்ட. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In முடுக்கப்பட்ட Today - Breaking & Trending Today

Welcome To IANS Live - SCIENCE AND TECHNOLOGY - Nvidia, VMware join hands to virtualise AI workloads

Nvidia unveiled AI Enterprise, a comprehensive software suite of enterprise-grade AI tools and frameworks, exclusively with VMware.The ....

News Service , India Private , Artificial Intelligence , All Rights , செய்தி சேவை , இந்தியா ப்ரைவேட் , செயற்கை உளவுத்துறை , அனைத்தும் உரிமைகள் ,

Relief Therapeutics Holding AG: NeuroRx Announced that RLF-100 has Demonstrated Ten-Day Accelerated Recovery from Respiratory Failure among Patients with Severe Covid-19 Treated with HFNO at 28 Day Interim Endpoint

GENEVA, SWITZERLAND / ACCESSWIRE / February 24, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lead compound RLF-100 (aviptadil) ....

United States , Anne Hennecke Brittney Sojeva , Raghuram Ram Selvaraju , Mc Services , Relief Therapeutics Holdings , Neurorx Inc , Swiss Exchange , Respiratory Failure , Co Vid , End Point , ஒன்றுபட்டது மாநிலங்களில் , ரகுராம் ரேம் செல்வராஜு , ம்ஸீ சேவைகள் , துயர் நீக்கம் சிகிச்சை ஹோல்டிங்ஸ் , சுவிஸ் பரிமாற்றம் , சுவாச தோல்வி , துயர் நீக்கம் , இணை வித் , முடிவு பாயஂட் ,

Basilea Pharmaceutica AG: Basilea launches a private placement of new shares by way of an accelerated bookbuilding

Basilea Pharmaceutica AG: Basilea launches a private placement of new shares by way of an accelerated bookbuilding
Basel, Switzerland, February 23, 2021
Basilea Pharmaceutica Ltd ( Basilea or the Company ) announced today the launch of an offering of up to 1 million new registered shares with a par value of CHF 1.00 per share. The net proceeds from this private placement will be used for i) the clinical development of Basilea s clinical oncology drug candidates derazantinib and lisavanbulin, ii) pre-clinical research and development activities, and iii) working capital and other general corporate purposes, including investments in or in-licensing of complementary businesses, products or assets.
The new shares correspond to approximately 8% of Basilea s currently issued share capital and will be issued from the Company s authorized share capital, excluding subscription rights of existing shareholders. The offer price of the new shares will be determined in an accelera ....

Basel Stadt , United States , United Kingdom , Nils Schr , Bryan Garnier , Head Of Corporate Communications Investor Relations , Credit Suisse , Financial Services , Swiss Exchange , Basilea Pharmaceutica Ltd , United Kingdom European Union Withdrawal , Swiss Financial Services , Cantor Fitzgerald , European Union , Basilea Press , Swiss Exchange On , Pharmaceutica Ltd , Securities Act , Joint Bookrunners , United Kingdom European Union , European Economic Area , United Kingdom Prospectus Regulation , Markets Act , Financial Promotion , Qualified Investors , Qualified Investor ,

Reply S p A : "Everything-as-an-interface" is the new paradigm resulting from Reply's "New Interfaces, Zero Interfaces" Research

February 22nd, 2021

The pandemic has accelerated the trend of adopting new interfaces in both consumer and professional fields, according to Reply s new research. | February 27, 2021 ....

Filippo Rizzante , Market Research , New Interfaces , Zero Interfaces , Artificial Intelligence Based , Reply Market Research , From Cloud , Replys Pa Stock Exchange , Press Release , New Rey It0005282865 , சந்தை ஆராய்ச்சி , புதியது இடைமுகங்கள் , பூஜ்யம் இடைமுகங்கள் , செயற்கை உளவுத்துறை அடிப்படையிலானது , பதில் சந்தை ஆராய்ச்சி , இருந்து மேகம் , ப்ரெஸ் வெளியீடு , சர்வதேச பரவல் ,

Accelerated Technologies Holding Corp. (OTC Markets: ATHC) Further Strengthens its Advisory Board with Appointment of Veteran Entrepreneur, Property Manager, Real Estate Developer, Hotelier, Business Leader Kent M. Swig

(2)
Noted iconic executive with proven track record in property management, real estate development and hotel management Kent Swig joins Accelerated Technologies Holding Corporation advisory board
NEW YORK CITY, NY / ACCESSWIRE / February 16, 2021 / Accelerated Technologies Holding Corp. (OTC PINK:ATHC) today announced the addition of Kent Swig to its Advisory Board.
Kent M. Swig is an executive with proven track record of developing, innovating and executing solutions to maximize investment returns, managing diverse organizations, multibillion dollar budgets and directing international efforts. He is an innovative thinker with a micromanaged, hands on goal-oriented approach with extensive expertise in effectively reimaging operating procedures, financial and marketing strategies. Mr. Swig s guidance will be instrumental in furthering ATHC s technological developments, enhancements and deployments to a variety on new industries. ....

New York , United States , Brown Harris Stevens , Alex Lemberg , Helmsley Spear , Technologies Holding Corporation , Technologies Holding Corp , Companies Do , Securities Exchange , Kent Swig , Accelerated Technologies Holding Corporation , Accelerated Technologies Holding , Swig Equities , Advisory Board , Real Estate , Property Management , Exchange Act , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , பழுப்பு ஹாரிஸ் ஸ்டீவன்ஸ் , அலெக்ஸ் லெம்பெர்க் , தொழில்நுட்பங்கள் வைத்திருத்தல் நிறுவனம் , தொழில்நுட்பங்கள் வைத்திருத்தல் கார்ப் , நிறுவனங்கள் செய் , பத்திரங்கள் பரிமாற்றம் , கேண்ட் ஸ்விக் ,